References

Citations

1. Fored CM, et al. (2001). Acetaminophen, aspirin, and chronic renal failure. New England Journal of Medicine, 345(25): 1801–1808.

2. Mackenzie H, Brenner BM (1998). Current strategiesfor retarding progression of renal disease. American Journal of Kidney Diseases, 31(1): 161–170.

3. Levey AS, et al. (2003). National Kidney Foundation practice guidelines for chronic kidney disease: Evaluation, classification, and stratification. Annals of Internal Medicine, 139(2): 137–147.

4. U.S. Department of Health and Human Services (2008). 2008 Physical Activity Guidelines for Americans (ODPHP Publication No. U0036). Washington, DC: U.S. Government Printing Office. Available online: http://www.health.gov/paguidelines/pdf/paguide.pdf.

5. Stigant C, et al. (2003). Nephrology: 4. Strategies for the care of adults with chronic kidney disease. Canadian Medical Association Journal, 168(12): 1553–1560.

6. Toto RD (2004). Approach to the patient with kidney disease. In BM Brenner, ed., Brenner and Rector's The Kidney, 7th ed., vol. 1, pp. 1079–1106. Philadelphia: Saunders.

7. Remuzzi G, Minetti L (2000).Hematologic consequences of renal failure. In BM Brenner et al., eds., Brenner and Rector's The Kidney, 6th ed., vol. 2, pp. 2079–2094. Philadelphia:W.B. Saunders.

Other Works Consulted

• Burkart JM, et al. (2004). Peritoneal dialysis. In BM Brenner, ed., Brenner and Rector's The Kidney, 7th ed., pp. 2625–2695. Philadelphia: Saunders.

• Cohen DP (2004). Chronic renal failure and dialysis. In DC Dale, DD Federman, eds., ACP Medicine, section 10, chap. 10. New York: WebMD.

• Fouque D, et al. (2007). Low-protein diets for chronic kidney disease in nondiabetic adults. Cochrane Database of Systematic Reviews (1).

• Gaston RS, et al. (2004). Transplantation in the diabetic patient with advanced chronic kidney disease: A task force report. American Journal of Kidney Diseases, 44(3): 529–542.

• Keith DS, et al. (2004). Longitudinal follow-up and outcomes among a population with chronic kidney disease in a large managed care organization. Archives of Internal Medicine, 164(6): 659–663.

• Klahr S, et al. (1994). The effects of dietary protein restriction and blood pressure control on the progression of chronic renal disease. New England Journal of Medicine, 330(13): 877–884.

• Kopple JD (2006). Nutrition, diet, and the kidney. Modern Nutrition in Health and Disease, 10th ed., pp. 1475–1511. Baltimore: Lippincott Williams and Wilkins.

• Magee CC, Pascual M (2004). Update in renal transplantation. Archives of Internal Medicine, 164(13): 1373–1388.

• Mitch WE, Walser M (2004). Nutritional therapy in renal disease. In BM Brenner, ed., Brenner and Rector's The Kidney, 7th ed., vol. 2, pp. 2491–2538. Philadelphia: Saunders.

• Remuzzi G, et al. (2004). Hematologic consequences of renal failure. In BM Brenner, ed., Brenner and Rector's The Kidney, 7th ed., vol. 2, pp. 2165–2188. Philadelphia: Saunders.

• Sarnak MJ, et al. (2005). The effect of lower target blood pressure on the progression of kidney disease: Long-term follow-up on the Modification of Diet in Renal Disease study. Annals of Internal Medicine, 142(5): 342–351.

• Schulman G, Himmelfarb J (2004). Hemodialysis. In BM Brenner, ed., Brenner and Rector's The Kidney, 7th ed., pp. 2563–2624. Philadelphia: Saunders.

• Shlipak MG, et al. (2005). Cardiovascular mortality risk in chronic kidney disease: Comparison of traditional and novel risk factors. JAMA, 293(14): 1737–1745.

• Wilkens KG (2004). Medical nutrition therapy for renal disorders. In LK Mahan, S Escott-Stump, eds., Krause’s Food Nutrition and Diet Therapy, 11th ed., pp. 961–996. Philadelphia: The Curtis Center.